Trial Profile
Add-on Simvastatin in Schizophrenia Trial.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms ASSIST
- 27 Apr 2012 Actual patient number 23 added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Jul 2011 Planned End Date changed from 1 Apr 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.